Recently, we developed an innovative Organ-on-chip (OoC) platform that is capable to transport cell culture media and circulating cells like blood without using pumps. The system is easy to use while allowing a high level of complexity with a process called “self-organization”.
Utilizing state-of-the-art stem cell technology, we can form organ models like a mini-liver or a miniaturized pancreas on-chip. These models can be grown from patient-specific cells to study individual drug response for instance to plan individual treatment or medication without the need to try out many different drugs.
This commercialization project focus on technical optimizations in order to develop a next-generation OoC platform for a broad range of organ models and studies thus giving us the opportunity to contribute in a fast growing market segment with a new startup within the next month.